Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
8,122,625
-
Total 13F shares
-
2,440,661
-
Share change
-
+20,303
-
Total reported value
-
$8,054,168
-
Price per share
-
$3.30
-
Number of holders
-
33
-
Value change
-
+$72,858
-
Number of buys
-
9
-
Number of sells
-
14
Institutional Holders of LUMOS PHARMA INC - Common Stock (LUMO) as of Q3 2023
As of 30 Sep 2023,
LUMOS PHARMA INC - Common Stock (LUMO) was held by
33 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,440,661 shares.
The largest 10 holders included
Blackstone Inc., WELLS FARGO & COMPANY/MN, GOLDMAN SACHS GROUP INC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Acuitas Investments, LLC, Jefferies Financial Group Inc., Lion Point Capital, LP, Greenwich Wealth Management LLC, and BRIDGEWAY CAPITAL MANAGEMENT, LLC.
This page lists
33
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.